Navigation Links
Business Opportunities in Spain's Fast-Growing Biotechnology Industry
Date:7/9/2009

MADRID, July 9 /PRNewswire/ --

- INVEST IN SPAIN would like to invite you to take part in an online seminar entitled "Business Opportunities in the Biotechnology, Pharma and Life Sciences Sector", in which business opportunities will be presented for foreign companies in the sector in Spain. Experts will respond to the questions of participants live.

- The seminar will be held on the 14th of July (12:00pm - 1:30pm Eastern Day Time or 6:00pm - 7:30pm Central European Time (GMT+1 in Spain)

- In order to attend the seminar, you have to first register for free using the following link: http://www.xtalks.com/events/xto341spain3/reg1.html

The biotechnology sector is one of the most dynamic in Spain. It has maintained an annual growth rate for turnover and job creation of 30% according to data from ASEBIO, the Spanish Association of Bio-companies. Spain attracts international projects and financing in biotechnology because it has a solid scientific base, highly qualified workforce, integrated health system, state-of-the-art infrastructures for innovation and major governmental backing. A fast-growing industry in a country with an extraordinary quality of life.

Business opportunities in Spain over the coming years will be linked to fields such as personalized medicine and advanced therapies, where interest is increasing in molecular diagnoses and related products.

In order to analyze opportunities in this field, the following people will participate in the online seminar: Jose Navas, Director of the Carlos III Health Institute, renowned for research into Cellular Therapy and Regenerative Medicine, and Eduardo Bravo, CEO of Cellerix, a company success story for foreign investment being as it is a Spanish company renowned internationally and with the participation of a range of foreign investors.

Enrique Vazquez Tatay, CEO of Neocodex, will also participate. Neocodex is a representative company in Spanish biotechnology development, and an example of the advanced technology and research capital available in Spain. Barbara Lopez, Head of Investor Services at INVEST IN SPAIN and Jorge Arenas Vidal, Director of Bioserentia, will make a general presentation of the sector. The seminar is open to questions from participants, will be held in English and will last approximately one and a half hours.

    For further information:http://www.investinspain.org

    Communication Office of Invest in Spain
    Cristina Exposito Peinado
    cexposito@investinspain.org
    Ana Garcia Camarillo
    agarcia@investinspain.org
    +34-91-503-5835



'/>"/>
SOURCE Invest in Spain
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. China Clean Energy Provides Business Update
2. Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business
3. SenesTech Announces New Vice President of Business Development
4. Gerresheimer Sells Technical Plastics Business
5. OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology
6. NeoStem Featured in Business Week; Promising Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article
7. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
8. CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
9. Next Stage Solutions Announces Three New Financial Services For Emerging Business
10. SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business
11. Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December 2016 that ... test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific for ... NAT screening for blood donors under an Investigational New Drug (IND) study protocol. ...
(Date:4/26/2017)...  Genisphere LLC, provider of the 3DNA ® ... and sponsored research agreement with the University of ... overall goal of the partnership is to study ... and formulations after in vivo administration. ... as well as inflammatory responses, demonstrating various methods ...
(Date:4/25/2017)... , April 25, 2017 ... has licensed its novel immune-modulating technology to an undisclosed ... and allergy. Tregitopes, pronounced T·rej·itopes, are ... immunoglobulin by EpiVax CEO Annie De Groot ... intravenous immunoglobulin G, an autoimmune disease therapy, Tregitopes ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... thermal denaturation in a cellular milieu; however, the broad application of this cellular ... simple platforms with sensitive quantitative readouts. Cell-based thermal stabilization assays are valuable methods ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):